Custics Singapore Wins South Korea's Outstanding Patent Award in Healthcare for 'Hautuki

Custics Singapore announced on the 18th that it has won the South Korea Outstanding Patent Award (Healthcare category) sponsored by the Korean Intellectual Property Office with its patent (patent registration number 10-1327555) enabling efficient absorption of large-molecule drugs through peptides.

An official stated, "Custics Singapore's 'Hautuki,' which won the award this time, is a patch-type product that is easily applied to the skin. In particular, we acquired the technology transfer of the patent for 'Peptides for Percutaneous Delivery through Pores Developed by Seoul National University Department of Biotechnology,' which enables the promotion of intra-body delivery of large-molecule drugs through skin-penetrating peptide ligands."

Continuing, they said, "While seeking an efficient method for administering vitamin D, we developed 'Hautuki' using the TDDS (Transdermal Drug Delivery System) method," and added, "We will continue to strive to launch Custics Singapore's patented TDDS products with convenience and efficiency by developing various nutrient products for consumers.